Company: STAA
Filing Date: 2025-09-18
Form Type: DFAN14A
Source: 0001213900-25-088801
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-09-18
Form: DFAN14A
Chunk 2
---
 transactions contemplated thereby (the "Compensation Proposal"). Details of the Merger Agreement Proposal, including information about the Reporting Persons reasons for opposing the Proposed Merger, can be found in the Preliminary Proxy Statement, which is available at no charge on the SEC's website at http://www.sec.gov. The Reporting Persons intend to commence the solicitation of proxies from the Issuer's stockholders after they have filed their definitive proxy statement with the SEC. Except as otherwise set forth herein, the Reporting Persons do not have any present plan or proposals which would relate to, or result in a change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; however, the Reporting Persons intend to review their investment in the Issuer and other plans or proposals related thereto on a continuing basis, and depending on various factors, including, but not limited to, the Issuer's financial position, a potential superior transaction in lieu of the Proposed Merger, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Issuer's interest in the Reporting Persons supporting the Issuer with the recruiting and nominating of new directors and executives, if necessary, to ensure that the Issuer fulfills its promise to patients, employees, business partners and stockholders. |
|:--------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Item 5. | Interest in Securities of the Issuer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| (a)     | Item 5 is hereby amended and restated in its entirety as follows: The aggregate percentage of Shares reported to be beneficially owned by the Reporting Persons is based upon 49,354,123 Shares outstanding as of September 12, 2025, as disclosed in the definitive proxy statement filed with the SEC by the Issuer on September 16, 2025. As of the date hereof, Broadwood Partners may be deemed to beneficially own 13,519,491 Shares, representing approximately 27.4% of the Shares outstanding. As of the date hereof, Broadwood Capital may be deemed to beneficially own 13,519,491 Shares